Biocorrx (OTCMKTS:BICX) Posts Earnings Results

Biocorrx (OTCMKTS:BICX) released its quarterly earnings results on Tuesday. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.11, Zacks reports. The business had revenue of ($0.15) million during the quarter, compared to analyst estimates of $0.22 million.

Biocorrx Price Performance

BICX stock remained flat at $0.40 during midday trading on Wednesday. The company had a trading volume of 200 shares, compared to its average volume of 1,219. The firm has a 50 day moving average of $0.35 and a two-hundred day moving average of $0.36. Biocorrx has a twelve month low of $0.20 and a twelve month high of $0.50. The company has a market cap of $10.56 million, a PE ratio of -1.25 and a beta of 0.33.

Biocorrx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.